The state food and drugs administration (FDA) department has confirmed the suspension of licence of the blood bank at Jaslok hospital for 15 days.
In March, the hospital received a suspension order after an FDA inquiry that took place after leukaemia patient, Deepti Makhijani, was given B-positive instead of A-positive blood in October last year. She died of multiple organ failure on December 8.
The order was stayed for a month after the hospital appealed to the FDA a few hours before the suspension was to come in force. A fresh hearing was held on April 26, following which the suspension was upheld, confirmed senior official from FDA minister Manohar Naik’s office.
“We are yet to decide the dates for suspension and we will soon issue orders specifying the 15-day period,” said a joint commissioner, FDA, Mumbai, requesting anonymity.
Medical director of the hospital Dr SK Mohanty said they had not received any written communication regarding the suspension.